CHANDRA BARTHOLOMEUSZ to MAP Kinase Kinase 1
This is a "connection" page, showing publications CHANDRA BARTHOLOMEUSZ has written about MAP Kinase Kinase 1.
Connection Strength
0.247
-
Anti-tumor and anti-metastasis efficacy of E6201, a MEK1 inhibitor, in preclinical models of triple-negative breast cancer. Breast Cancer Res Treat. 2019 Jun; 175(2):339-351.
Score: 0.154
-
MEK1/2 inhibitor selumetinib (AZD6244) inhibits growth of ovarian clear cell carcinoma in a PEA-15-dependent manner in a mouse xenograft model. Mol Cancer Ther. 2012 Feb; 11(2):360-9.
Score: 0.093